BioCardia BCDA
NASDAQ BCDA
$0.98 -0.06 (-5.54%)
At close: Oct 21, 2026 · 4:00 PM EDT

BioCardia (BCDA) Debt Ratio (2010 - 2020)

Updated

BioCardia's (BCDA) Debt Ratio stood at 0.05 in Q3 2020, up 38.7% from the prior quarter.

Analysis

BioCardia (BCDA) Debt Ratio (2010 - 2020) Analysis & Trends

For FY2015, BioCardia's Debt Ratio came in at 1.17.

  • The Q3 2020 figure is the highest quarterly Debt Ratio since Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 BioCardia 11.85 Mn -1.01 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 0.05
Jun 30, 2020 0.04
Dec 31, 2015 1.17
Dec 31, 2010 0.09
API Access

BioCardia Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=BCDA&period=max&api_key=YOUR_API_KEY